English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
5 天
印度制药公司将以低90%的价格推出糖尿病仿制药
根据《印度时报》的报道,业内专家指出,随着Boehringer Ingelheim公司关于Empagliflozin的专利在3月11日到期,多家印度制药企业正计划推出该糖尿病药物的仿制版本,并预计以显著较低的价格进行市场竞争。
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Deportation order blocked
US launches strikes in Yemen
Pleads not guilty
Chiefs sign Tillery
Consumer sentiment drops
Gold rises to new heights
Trump signs funding bill
Laceration hazard recall
Severe weather outbreak
Senate confirmation hearing
Israeli attack in Gaza
Influential WY senator dies
Child abuse images sentence
Kupp signs with Seahawks
US expels SA ambassador
Syed formally resentenced
Cuba suffers power outage
Electrical fire halts show
Second protester arrested
Top intelligence agency visit
SK: Massive rallies erupt
Withdraws nomination
Felony gun possession arrest
Man wins $50M over burns
RU, UKR launch attacks
Coffee creamer recall
ISIS leader killed in Iraq
Kellogg's envoy role reduced
Wins longest-ever Iditarod
Influencer leaves Australia
反馈